Fairvalue-Calculator Fairvalue-Calculator
EN DE

CareRx Corporation (CRRX) Fair Value & Analysis

Healthcare · CA · Market cap C$204M

PriceC$3.32
Fair ValueC$6.26
Upside+88.6%
Quality95/100
Evidence: High Range C$3.55 – C$8.75

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

CareRx Corporation (CRRX) currently trades at C$3.32, while our model-based Fair Value estimate is C$6.26 — implying the stock looks roughly 88.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -25% 5225 (5225) -70% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) -7% Tenet Healthcare Corporation (THC) +74%

Frequently asked questions

Is CareRx Corporation (CRRX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of C$6.26 versus a price of C$3.32 — about +89% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CRRX?
Our 21-model fair value for CareRx Corporation is C$6.26 (as of Jun 24, 2026), built from audited fundamentals. The current price is C$3.32.
What is the quality score of CRRX?
CareRx Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.